The European Medicines Agency (EMA) gave the green light on Friday for the use of the Moderna vaccine against the coronavirus for 12-17 year olds.
This vaccine therefore becomes the second authorized for adolescents in the European Union.
The European Medicines Agency (EMA) on Friday approved the use of the anti-Covid Moderna vaccine for 12-17 year olds, which becomes the second vaccine to be authorized for adolescents in the 27 countries of the European Union .
"The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended to grant an indication extension for the COVID-19 vaccine Spikevax (formerly Covid-19 Vaccine Moderna) to include its use in children aged 12 to 17 years old, "the European regulator said in a statement.
>> More information to follow